Accordingly, development of MAO-B inhibitors seems to be an interesting strategy to deepen our knowledge on diseases characterized by neuroinflammatory conditions, like AD and Parkinson disease (PD) [59]. The gene discussed is MAOB; the disease is Alzheimer disease.